Sara Tolaney
Medical oncologist at Dana-Farber Cancer Institute specializing in breast cancer research and clinical trials, providing detailed analysis of recent ADC datasets and practical treatment implications.
Best podcasts with Sara Tolaney
Ranked by the Snipd community
5 snips
Feb 28, 2026 • 59min
Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Dr Sara M Tolaney, a Dana-Farber breast cancer researcher, and Dr Hope S Rugo, a City of Hope clinical trial expert, review antibody-drug conjugate trial data and treatment choices. They compare ADC options for HER2-low, HER2-positive, and triple-negative disease. They discuss sequencing, toxicity tradeoffs, brain metastasis management, ILD risk, and combining ADCs with immunotherapy.
Nov 24, 2025 • 24min
Challenging Cases in Breast Cancer with CDK 4/6 Inhibitors – Drs. Sara Tolaney & Adam Brufsky
Dr. Sara Tolaney, a breast cancer researcher at Dana-Farber, and Dr. Adam Brufsky from UPMC Hillman, dive into the latest advancements in CDK4/6 inhibitors. They discuss key trial updates, recommending abemaciclib for high-risk patients and exploring dosing strategies to manage side effects like diarrhea and neutropenia. Insights on tailoring treatment for metastatic cases and considering patient comorbidities highlight the importance of individualized care. Expect expert opinions on navigating the complexities of breast cancer therapeutics!
